|
|
40
|
0633X
|
UNITREXATE 25MG/ML INJ (UBI/RXP) METHOTREXATE
|
2ML VIAL
|
B
|
7.07
|
25MG/ML
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
0633Z
|
ZUVITREX 25MG/ML INJ (ZUV) METHOTREXATE (B)
|
2ML VIAL
|
B
|
5.1104
|
25MG/ML
|
5
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
40
|
0634M
|
METHOTREXATE 25MG/ML INJ (INP/AHI)
|
20ML VIAL
|
BQ
|
46.43
|
25MG/ML
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
40
|
06351
|
METHOTREXATE 25MG/ML INJ (INP/AHI)
|
40ML
|
BQ
|
82.12
|
25MG/ML
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
40
|
06417
|
ACCORD MITOMYCIN 5MG INJ (INP/AAL) MITOMYCIN
|
5MG VIAL
|
BQ
|
203.06
|
5MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
40
|
0671D
|
UNIBLASTIN 10MG INJ (UBI/RXP) VINBLASTINE
|
10MG VIAL
|
BQ
|
54.37
|
10MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
0671F
|
VINBLASTINE 10MG INJ (KWA) (BQ)
|
10MG VIAL
|
BQ
|
26.9386
|
10MG
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
40
|
0681Q
|
UNICRISTINE 1MG INJ (UBI/RXP) VINCRISTINE
|
1MG VIAL
|
BQ
|
7.07
|
1MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
42
|
0681S
|
BIOCRISTIN INJ (ZYD)
|
1ML VIAL
|
BQ
|
13.70
|
1MG/ML
|
8
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
41
|
06926
|
NEOSTIGMINE 2.5MG/ML INJ (ANT) (BQ)
|
10X1ML
|
BQ
|
4.6212
|
2.5MG/ML
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
42
|
06928
|
NEOSTIGMINE 2.5MG/ML INJ (MON)
|
10X1ML
|
BQ
|
1.32
|
2.5MG/ML
|
0
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
40
|
0692H
|
NEOSTIGMINE 2.5MG/ML INJ (SGH/COL)
|
10X1ML
|
BQ
|
1.71
|
2.5MG/ML
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
40
|
0692J
|
LASTIGMINE 2.5MG/ML INJ (LDP/AHI)
|
5X1ML
|
BQ
|
3.40
|
2.5MG/ML
|
0
|
2022-04-01
|
2022-09-30
|
|
|
|
0
|
|
|
40
|
0692L
|
NEOSTIGMINE 2.5MG/ML INJ (MON/PHA)
|
5X1ML
|
BQ
|
1.57
|
2.5MG/ML
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
42
|
0692P
|
NEOSTIGMINE 2.5MG/ML INJ (FSB)
|
10X1ML
|
BQ
|
0.78
|
2.5MG/ML
|
0
|
2026-04-01
|
|
No
|
No
|
Add to Contract
|
0
|
|
|
40
|
0694A
|
NEOSTIGMINE 2.5MG/ML INJ (MON/PHA)
|
5X5ML
|
BQ
|
3.83
|
2.5MG/ML
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
42
|
0694A
|
NEOSTIGMINE 2.5MG/ML INJ (MON)
|
5X5ML
|
BQ
|
3.10
|
2.5MG/ML
|
0
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
41
|
0694B
|
NEOSTIGMINE 2.5MG/ML INJ (OMG) (BQ)
|
10X5ML
|
BQ
|
10.104
|
2.5MG/ML
|
0
|
2024-04-01
|
2024-07-19
|
|
|
|
0
|
|
|
41
|
0694B
|
NEOSTIGMINE 2.5MG/ML INJ (OMG) (BQ)
|
10X5ML
|
BQ
|
8.664
|
2.5MG/ML
|
0
|
2024-07-20
|
2026-03-31
|
|
|
|
0
|
|
|
40
|
0694C
|
LASTIGMINE PLUS 2.5MG/ML INJ (LDP/AHI)
|
5X5ML
|
BQ
|
5.22
|
2.5MG/ML
|
0
|
2022-04-01
|
2022-09-30
|
|
|
|
0
|
